Development of a provisional core set of response measures for clinical trials of systemic sclerosis.
about
Citation analysis did not provide a reliable assessment of core outcome set uptakeDevelopment of Clinical Trial Assessments for the Study of Interstitial Lung Disease in Patients who have Connective Tissue Diseases-Methodological Considerations.Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards.Methods of formal consensus in classification/diagnostic criteria and guideline development.Assessment of chronic post-surgical pain after knee replacement: development of a core outcome set.The Importance of Integration of Stakeholder Views in Core Outcome Set Development: Otitis Media with Effusion in Children with Cleft Palate.Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis.Correlates and responsiveness to change of measures of skin and musculoskeletal disease in early diffuse systemic sclerosis.Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosisThe American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic SclerosisTrial design: how must we move ahead?A standardized core set for systemic sclerosis clinical trials. First step in development of combined response indexMinimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial--results from the Scleroderma Lung Study.The symptom burden index: development and initial findings from use with patients with systemic sclerosis.Update on juvenile systemic sclerosis.Clinical Trial Design Issues in Systemic Sclerosis: an Update.Validity and responsiveness of the Michigan Hand Questionnaire in patients with systemic sclerosis.The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic SclerosisReliability and Validity of the Tender and Swollen Joint Counts and the Modified Rodnan Skin Score in Early Diffuse Cutaneous Systemic Sclerosis: Analysis from the Prospective Registry of Early Systemic Sclerosis Cohort.COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis."It's Not Me, It's Not Really Me." Insights From Patients on Living With Systemic Sclerosis: An Interview Study.Assessment of skin involvement in systemic sclerosis.A multi-national qualitative research study exploring the patient experience of Raynaud's phenomenon in systemic sclerosis.American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis.Which outcomes are most important to people with aphasia and their families? an international nominal group technique study framed within the ICF.Measuring outcomes in aphasia research: A review of current practice and an agenda for standardisation
P2860
Q33910843-F7EB35AD-C2F7-46C0-905A-CA30285A2F2AQ34027159-0F14EC4E-C598-44A4-A160-AF65E9563296Q34727670-F0CA1878-4B83-4EDF-B9D5-4DBF7625A610Q35091202-F0D00FB4-EABB-45E4-9852-C768457F048BQ35535771-62FD8706-ADCB-4415-8919-B37087BB6C6CQ35675722-32686BE6-19A1-4D3D-8C1F-23602919F3B8Q35851777-E94CF89F-98BB-4FBA-976B-CF8E6DA9BE4CQ35878701-3A5B2DE4-1134-42C1-B801-155C09CDF636Q35977294-1C9A1C33-3455-4D8E-911D-210C1C2EFE86Q36758822-AB527717-C623-4D33-9211-E37D95895611Q36869407-C1658226-F571-4133-9CA9-0CE05AAE1158Q36869412-7FB52A3F-B730-4E59-A1AF-86519BEE4EBAQ37421246-D4F58B06-93A3-4826-A53D-CA3955F0A856Q37460765-12260995-F645-45B3-9955-3DD603CA25E8Q38374314-A7DED12D-4DDC-4287-88FD-772EE4A571DFQ38825869-F313D305-E1A8-492F-AD59-51131678A44DQ39853680-4BCF21CA-4D10-4D10-BFCC-973887780DB0Q40002833-0DB14413-6466-464B-AE34-71B2CAC09BC7Q40290418-7C432A41-896D-48C4-A109-8CF5130808EEQ47107888-F92DFAAB-FE85-4FE0-8CDC-87800BB00E1BQ47349444-FA64FF35-02CF-4E16-93CD-3122D7110B29Q47835767-604A9949-8056-4CAF-8623-3B70C6172366Q52374296-445EA9E8-95D8-4E44-9D5D-FA225000B076Q53150640-27376995-3B65-427F-9FB4-3B06BDA56C90Q55059772-572808DD-77AE-4AF7-99B5-FE784CD6BAD9Q58270967-93DC9A91-823C-466D-BC0C-A83ABD5AF762
P2860
Development of a provisional core set of response measures for clinical trials of systemic sclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 September 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of a provisional c ...... trials of systemic sclerosis.
@en
Development of a provisional c ...... trials of systemic sclerosis.
@nl
type
label
Development of a provisional c ...... trials of systemic sclerosis.
@en
Development of a provisional c ...... trials of systemic sclerosis.
@nl
prefLabel
Development of a provisional c ...... trials of systemic sclerosis.
@en
Development of a provisional c ...... trials of systemic sclerosis.
@nl
P2093
P2860
P356
P1476
Development of a provisional c ...... trials of systemic sclerosis.
@en
P2093
C P Denton
D J Lovell
E Giannini
J R Seibold
P A Merkel
P J Clements
P2860
P304
P356
10.1136/ARD.2007.078923
P407
P577
2007-09-24T00:00:00Z